{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:32:04Z","timestamp":1790429524059,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1097\/mnm.0b013e3282f1bbf5","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T03:02:14Z","timestamp":1236222134000},"page":"17-26","source":"Crossref","is-referenced-by-count":16,"title":["Reduced thalamic 18F-flurodeoxyglucose retention in adults with neurofibromatosis type 1"],"prefix":"10.1097","volume":"29","author":[{"given":"Ralph","family":"Buchert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"von Borczyskowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Wilke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gronowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard E.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janos","family":"Mester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor F.","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8","article-title":"Epidemiology of neurofibromatosis type 1","volume":"89","author":"Friedman","year":"1999","journal-title":"Am J Med Genet"},{"key":"R2-4-20210212","first-page":"315","article-title":"Neurofibromatosis von Recklinghausen type 1 \u2013 current knowledge","volume":"67","author":"Petrak","year":"2004","journal-title":"Cesk Slov Neurol Neurochir"},{"key":"R3-4-20210212","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/WNL.48.4.1121","article-title":"Cognitive function and academic performance in neurofibromatosis 1: Consensus statement from the NF1 cognitive disorders task force","volume":"48","author":"North","year":"1997","journal-title":"Neurology"},{"key":"R4-4-20210212","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/1096-8628(200022)97:2<119::AID-AJMG3>3.0.CO;2-3","article-title":"Neurofibromatosis type 1","volume":"97","author":"North","year":"2000","journal-title":"Am J Med Genet"},{"key":"R6-4-20210212","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/088307389701200807","article-title":"Positron emission tomography in children with neurofibromatosis-1","volume":"12","author":"Kaplan","year":"1997","journal-title":"J Child Neurol"},{"key":"R7-4-20210212","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/jnnp.57.12.1479","article-title":"Cerebral glucose metabolism in neurofibromatosis type 1 assessed with [18F]-2-fluoro-2-deoxy-D-glucose and PET","volume":"57","author":"Balestri","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R8-4-20210212","article-title":"Neurofibromatosis. Phenotype, natural history and pathogenesis","author":"Riccardi","year":"1986"},{"key":"R9-4-20210212","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-0404.1997.tb00103.x","article-title":"Neuropsychological deficits in adults with neurofibromatosis type 1","volume":"95","author":"Zoller","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"R10-4-20210212","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1212\/01.WNL.0000055090.78351.C1","article-title":"Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1","volume":"60","author":"Hyman","year":"2003","journal-title":"Neurology"},{"key":"R11-4-20210212","first-page":"1573","article-title":"International consensus statement on malignant peripheral nerve sheath tumours in neurofibromatosis","volume":"62","author":"Ferner","year":"2002","journal-title":"Cancer Res"},{"key":"R12-4-20210212","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00259-005-0030-1","article-title":"Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours","volume":"33","author":"Brenner","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R13-4-20210212","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1997.03550010065042","article-title":"The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2","volume":"278","author":"Gutmann","year":"1997","journal-title":"JAMA"},{"key":"R14-4-20210212","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF01377205","article-title":"MRI findings in children with neurofibromatosis type 1: a prospective study","volume":"26","author":"Van Es","year":"1996","journal-title":"Pediatr Radiol"},{"key":"R15-4-20210212","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.56.5.492","article-title":"MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment","volume":"56","author":"Ferner","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R16-4-20210212","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1212\/01.WNL.0000098881.95854.5F","article-title":"Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities","volume":"61","author":"Feldmann","year":"2003","journal-title":"Neurology"},{"key":"R17-4-20210212","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1177\/08830738040190110201","article-title":"T2-weighted hyperintensities (unidentified bright objects) in children with neurofibromatosis 1: their impact on cognitive function","volume":"19","author":"Goh","year":"2004","journal-title":"J Child Neurol"},{"key":"R18-4-20210212","first-page":"885","article-title":"The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder","volume":"150","author":"Ward","year":"1993","journal-title":"Am J Psychiatry"},{"key":"R19-4-20210212","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s001150050311","article-title":"Hyperkinetic syndrome (attention deficit\/hyperactivity disorder) in adulthood","volume":"69","author":"Krause","year":"1998","journal-title":"Nervenarzt"},{"key":"R20-4-20210212","article-title":"Brown attention-deficit disorder scales, manual","author":"Brown","year":"1996"},{"key":"R21-4-20210212","article-title":"Manual for the child behavior checklist\/4-18 and 1991 profile","author":"Achenbach","year":"1991"},{"key":"R23-4-20210212","article-title":"Interpretation of psychological tests","author":"Leark","year":"2000"},{"key":"R24-4-20210212","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00006231-200411000-00005","article-title":"Validation of quantitative accuracy of the post-injection transmission-based and transmissionless attenuation correction techniques in neurological FDG-PET","volume":"25","author":"Kaneko","year":"2004","journal-title":"Nucl Med Commun"},{"key":"R25-4-20210212","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"key":"R26-4-20210212","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/nimg.1998.0346","article-title":"Regional changes in glucose metabolism during brain development from the age of 6 years","volume":"8","author":"Van Bogaert","year":"1998","journal-title":"Neuroimage"},{"key":"R27-4-20210212","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.46.6.1660","article-title":"Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis","volume":"46","author":"Moore","year":"1996","journal-title":"Neurology"},{"key":"R28-4-20210212","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/1531-8249(200004)47:4<477::AID-ANA11>3.0.CO;2-C","article-title":"Thalamic involvement in neurofibromatosis type 1: evaluation with proton magnetic resonance spectroscopic imaging","volume":"47","author":"Wang","year":"2000","journal-title":"Ann Neurol"},{"key":"R29-4-20210212","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1148\/radiology.219.2.r01ap25354","article-title":"Increased brain apparent diffusion coefficient in children with neurofibromatosis type 1","volume":"219","author":"Eastwood","year":"2001","journal-title":"Radiology"},{"key":"R30-4-20210212","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.rct.0000162406.71300.b7","article-title":"Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1","volume":"29","author":"Tognini","year":"2005","journal-title":"J Comput Assist Tomogr"},{"key":"R31-4-20210212","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejrad.2005.05.008","article-title":"Neurofibromatosis type 1: diffusion weighted imaging findings of brain","volume":"56","author":"Alkan","year":"2005","journal-title":"Eur J Radiol"},{"key":"R32-4-20210212","doi-asserted-by":"crossref","first-page":"6010","DOI":"10.1073\/pnas.82.17.6010","article-title":"Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat","volume":"82","author":"Kadekaro","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-4-20210212","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/(SICI)1096-8628(19960409)67:2<127::AID-AJMG1>3.0.CO;2-P","article-title":"Neurobehavioral profiles of children with neurofibromatosis 1 referred for learning disabilities are sex-specific","volume":"67","author":"Chapman","year":"1996","journal-title":"Am J Med Genet"},{"key":"R34-4-20210212","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-510X(96)00022-6","article-title":"Intellectual impairment in neurofibromatosis 1","volume":"138","author":"Ferner","year":"1996","journal-title":"J Neurol Sci"},{"key":"R35-4-20210212","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/nimg.1999.0477","article-title":"Validation of statistical parametric mapping (SPM) in assessing cerebral lesions: A simulation study","volume":"10","author":"Stamatakis","year":"1999","journal-title":"Neuroimage"},{"key":"R36-4-20210212","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00259-006-0067-9","article-title":"IBZM tool: a fully automated expert system for the evaluation of IBZM SPECT studies","volume":"33","author":"Buchert","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R37-4-20210212","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.410060502","article-title":"Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method","volume":"6","author":"Phelps","year":"1979","journal-title":"Ann Neurol"},{"key":"R38-4-20210212","first-page":"E69","article-title":"Noninvasive determination of local cerebral metabolic rate of glucose in man","volume":"238","author":"Huang","year":"1980","journal-title":"Am J Physiol"},{"key":"R39-4-20210212","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF02984652","article-title":"Necessity of a uniform start for scanning after FDG injection in brain PET study","volume":"20","author":"Ishii","year":"2006","journal-title":"Ann Nucl Med"},{"key":"R40-4-20210212","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00004728-198406000-00028","article-title":"Analysis of emission tomographic scan data: limitations imposed by resolution and background","volume":"8","author":"Kessler","year":"1984","journal-title":"J Comput Assist Tomogr"},{"key":"R41-4-20210212","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1212\/WNL.54.4.914","article-title":"Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status","volume":"54","author":"Moore","year":"2000","journal-title":"Neurology"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006231-200801000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:44:26Z","timestamp":1618037066000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-200801000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e3282f1bbf5","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}